Dated disclosed rounds · latest 2024-07-16
Later stage / growth
Huma Therapeutics
Digital health AI platform; Remote patient monitoring / digital health cloud platform
VerifiedSeries DLondon
- Companies House
- 07725451
- GLEIF LEI
- 213800RKLMVGUGR83636
- Latest evidence
- 2024-07-16
- Evidence snapshot
- 2026-08-25
Exact award notices · latest No exact award match
2026-08-25T03:27:22.329Z
Jun 2026
Signals organise dated evidence; they do not score growth, revenue, creditworthiness or investment performance.
Evidence timeline
5 dated observations
Funding, procurement, registry and identifier records are placed on one chronology. Each row says whether it is a source fact, a record observation or reference metadata; no inferred event is inserted.
RegistryRecord observation Status observed: Active
Snapshot evidence only; this row does not claim the status changed on this date.
IdentifierReference metadata LEI record updated
213800RKLMVGUGR83636 · registration ISSUED
FundingSource fact Series D
$80M / £61.7M · 4 named investors
IdentifierReference metadata LEI first registered
213800RKLMVGUGR83636
RegistryRegistry fact Company incorporated
HUMA THERAPEUTICS LIMITED · company 07725451
Latest disclosed round
Series D
- Date
- 2024-07-16
- Amount
- USD 80m
- Sector
- AI / ML / data; Healthtech & digital health
- Companies House
- 07725451
- ONS region
- London
Evidence status
Directory ready
- Identity
- Verified
- Match
- High — exact company number and aligned registered name
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
4 linked investors
Lead, participant, lender and other retained roles remain distinct where the source supports them. Every relationship below names its source layer, observation date, match method and publication state.
AstraZenecaparticipantHAT Technology Fund 4participantHitachi VenturesparticipantLeaps by Bayerparticipant
| Investor | Role | Date | Source | Match / state |
|---|---|---|---|---|
| AstraZeneca | participant | 2024-07-16 | Huma ↗ · Fiercebiotech ↗ · Sifted ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| HAT Technology Fund 4 | participant | 2024-07-01 | Huma ↗ · Fiercebiotech ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Hitachi Ventures | participant | 2024-07-16 | Huma ↗ · Fiercebiotech ↗ · Sifted ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Leaps by Bayer | participant | 2024-07-16 | Huma ↗ · Fiercebiotech ↗ · Sifted ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
Funding record
1 disclosed round
Open a dated round to move directly between the company, named investors and source publication.
| Date | Stage | Amount | Investors | Named sources |
|---|---|---|---|---|
| 2024-07-16 | Series D | $80M / £61.7M | AstraZeneca · HAT Technology Fund 4 · Hitachi Ventures · Leaps by Bayer | Huma ↗ · Fiercebiotech ↗ · Sifted ↗ |
Companies House status and filing snapshot
HUMA THERAPEUTICS LIMITED
Exact company-number match from the public register. The retained status is active. Filing dates and SIC codes are registry context, not a credit or investment-quality assessment.
Registered record
- Status
- Active
- Company type
- Private Limited Company
- Country of origin
- United Kingdom
- Incorporated
- 2011-08-02
- Dissolved
- Not applicable
- Company number
- 07725451
Filing context
- Accounts category
- GROUP
- Accounts made up to
- 2024-12-31
- Next accounts due
- 2026-09-29
- Confirmation made up to
- 2025-11-25
- Registry snapshot
- 2026-08-01
- Live check
- 2026-08-25T03:27:22.329Z
Former registered names: HUMAFORHEALTH LIMITED, MEDOPAD LTD
61900Other telecommunications activities62090Other information technology service activities
Global legal-entity identifier
213800RKLMVGUGR83636
Exact company-number match to the GLEIF golden-copy data. An LEI is an identifier for a legal entity; it is not a credit, risk or investment-quality rating.
GLEIF record
- Legal name
- HUMA THERAPEUTICS LIMITED
- Entity status
- ACTIVE
- Jurisdiction
- GB
- Registration status
- ISSUED
- Last updated
- 2026-07-17T15:18:23.203Z
- Next renewal
- 2027-07-17T00:00:00Z
CompanyBeacon statutory projection
HUMA THERAPEUTICS LIMITED
UK Capital Intelligence owns the capital view on this page. CompanyBeacon owns the exact legal-entity, filing, control and public-record timeline for company number 07725451.
Latest retained status
active
- Checked
- 2026-08-25T03:27:22.329Z
- Recorded change
- No change timestamp retained
- Previous status
- active
- Fund associations
- 1 dated CompanyBeacon membership
Boundary
Verify the legal record
Fund association does not prove a current holding. Status change is a review signal, not investment performance or wrongdoing. Ownership and control are not copied into this public UKCI package.
Open CompanyBeacon record ↗Traceability
Source trail
Funding and investor claims retain named public-source links. This is a dated research snapshot, not a live cap table.